Clinical Trial Update: A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating daily dosing with levalbuterol, racemic albuterol, and placebo in pediatric subjects with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol (racemic) (albuterol)
• Levalbuterol (Xopenex) (levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED